Wakamoto Pharmaceutical Co., Ltd.

Tdk Corporation

Sony Corporation

Metawater Co., Ltd.

Renesas Electronics Corporation

Tokyo Metropolitan Sewerage Service Corporation

Makoto Maeda

Touru Oguma

Masahiro Yoshida

Kosuke Takano

Hiroyuki Takahashi

Satoshi Yamazaki

Hidekazu Suzuki

Hiroki Maruyama

Tamotsu Ishiyama

Tsutomu Wada

Tomohisa Fukuoka

Masahide Ishizuya

Masanobu Takeuchi

Shigehiro Suzuki

Yuhta Matsunaga

Yoshikazu Naito

Nobuki Tsuboi

Hiroe Suzuki

Yuji Furuya

Noriaki Inagaki

Takashi Aoki

Nobuyuki Suzuki

Katsumi Kobayashi

Masatake Hayashi

Sunao Masuda

Takahiro Wada

Toshihiro Kuroshima

Nobuto Morigasaki

Mari Miyauchi

Kenji Endo

Hideaki Seki

Toshie Takahashi

Hiroji Sumiyoshi

Haruhisa Hirata

Hatsunori Toyofuku

Michio Tamura

Seigo Nakaya

Kenji Naito

Mitsuji Agata

Yoshitami Ohashi

Daisuke Morizono

Ryoki Takahashi

Kaei Nagoshi

Noriko Tahira

Reiko Hirata

Kouji Kassai

Yuji Aiba

Azusa Katou

Keiichi Sone

Naomi Kokubo

Keiko Naito

Miyako Sasaki

Provided are a wireless communication apparatus, a system and a method that are suitable for establishing steady communication by using a redundant configuration. The wireless communication apparatus includes a plurality of devices that transmit and receive data through a wireless network. The devices each include a control section and a decision section. The decision section in one of the devices designates a first device from among the devices as a first valid device, and designates a second device as a second valid device. The control section in the first device copies to the second device the data and coupling information for transmitting and receiving the data. When the second device is determined to valid, the control section in the second device transmits the copied data from the second device.

Wireless communication apparatus, system, and method

An external terminalcomprises a terminal electrode connection partconnected to the terminal electrodeto face to the end surface of the element body; a mounting connection partconnectable to a mounting surface; and a joint partwhich joins the terminal electrode connection partwith the mounting connection partto separate one side surfaceof the element bodyclosest to the mounting surfacetherefrom. A width Wof the joint partalong a direction parallel to the mounting surfaceis smaller than a width Wof the terminal electrode connection part

Electronic device comprising chip component and external terminal

A wastewater treatment apparatus includes: an air diffusing unit that supplies gas to nitrogen-containing water, so that ammonia contained in the nitrogen-containing water is nitrified to nitrate according to a flow of the water, and each desired proportion of the nitrate is denitrified at each position along the flow direction; a denitrification confirming unit provided at a halfway position between an upstream-side denitrification zone for obtaining a requisite minimum denitrified nitrogen amount and a downstream-side nitrification zone for obtaining ultimately required nitrified water quality, which follows the upstream-side denitrification zone on a downstream side thereof; and a gas supply-amount control unit that controls a gas supply amount from the air diffusing unit at least on an upstream side of the denitrification confirming unit, so that a desired proportion of the nitrate is denitrified at the halfway position, based on the denitrification state confirmed by the denitrification confirming unit.

Wastewater treatment apparatus, wastewater treatment method, wastewater treatment system, control device, and control method

A wastewater treatment apparatus includes an air diffusing unit, a denitrification confirming unit, a nitrification confirming unit, a gas supply-amount control unit. The air diffusing unit supplies gas to nitrogen-containing water. The denitrification confirming unit provided at a first predetermined position confirms a denitrification state whether a desired proportion of the nitrate has been denitrified. The nitrification confirming unit provided at a second predetermined position confirms a nitrification state whether a desired proportion of the ammonia has been nitrified. The gas supply-amount control unit controls a gas supply amount at least on an upstream side of the denitrification confirming unit, so that the desired proportion of the nitrate is denitrified at the first predetermined position, and controls the gas supply amount at least on an upstream side of the nitrification confirming unit, so that the desired proportion of the ammonia is nitrified at the second predetermined position.

A dielectric ceramic composition comprises, a main component including barium titanate, a first subcomponent including MgO, a second subcomponent including sintering aids of SiOcompound, a third subcomponent including at least one of VO, NbOand WO, a fourth A subcomponent including Roxide (note that, Ris at least one selected from Tb, Gd and Dy), a fourth B subcomponent including Roxide (note that, Ris at least one selected from Ho, Y and Yb), and a fifth subcomponent including MnO or CrO.

Dielectric ceramic composition and an electronic component

A dielectric ceramic composition includes a compound having perovskite type crystal structure shown by a general formula ABO, where A is at least one selected from Ba, Ca and Sr, and B is at least one selected from Ti and Zr, as a main component. The dielectric ceramic composition includes, as subcomponents, with respect to 100 moles of the compound, 1.0 to 2.5 moles of an oxide of RA (Dy, Gd and Tb); 0.2 to 1.0 mole of an oxide of RB (Ho and Y); 0.1 to 1.0 mole of an oxide of RC (Yb and Lu); 0.8 to 2.0 moles of Mg oxide and 1.2 to 3.0 moles of an oxide including Si in terms of RAO, RBO, RCO, Mg and Si, respectively. Also, when contents of the oxide of RA, RB and RC with respect to 100 moles of the compound are defined as '&#x3b1;', '&#x3b2;' and &#x201c;&#x3b3;&#x201d;, respectively, the &#x201c;&#x3b1;&#x201d;, &#x201c;&#x3b2;&#x201d; and &#x201c;&#x3b3;&#x201d; satisfy relations of 2.5&#x2266;(&#x3b1;/&#x3b2;)&#x2266;5.0 and 1.0&#x2266;(&#x3b2;/&#x3b3;)&#x2266;10.0. According to the present invention, a dielectric ceramic composition having good properties can be provided.

Dielectric ceramic composition and ceramic electronic component

A dielectric ceramic composition includes a compound having perovskite type crystal structure shown by a general formula ABO, where A is at least one selected from Ba, Ca and Sr, and B is at least one selected from Ti and Zr. The dielectric ceramic composition includes, as subcomponents, an oxide of RA (Dy, Gd and Tb); an oxide of RB (Ho and Y); an oxide of RC (Yb and Lu); Mg oxide and an oxide including Si in terms of RAO, RBO, RCO, Mg and Si, respectively. Also, when contents of the oxide of RA, RB and RC with respect to 100 moles of the compound are defined as '&#x3b1;', '&#x3b2;' and &#x201c;&#x3b3;&#x201d;, respectively, they satisfy relations of 1.2&#x2266;(&#x3b1;/&#x3b2;)&#x2266;5.0 and 0.5&#x2266;(&#x3b2;/&#x3b3;)&#x2266;10.0.

O/W emulsion composition for eye drops

Anti-inflammatory eye drop

Lyophilized pharmaceutical preparations capable of providing aqueous

A lipid emulsion which comprises (A) an oil component, (B) an emulsifying agent containing yolk lecithin and/or soybean lecithin, and (C) water, wherein the lipid emulsion further comprises citric acid or a pharmaceutically acceptable salt thereof and at least one member selected from the group consisting of methionine, phenylalanine, serine, histidine and pharmaceutically acceptable salts thereof, provided that it does not simultaneously contain methionine and phenylalanine. The addition of citric acid and histidine, methionine, phenylalanine and/or serine to a lipid emulsion containing natural lecithin as an emulsifying agent permits the prevention of change of color and formation of oil drops associated with the conventional natural lecithin-containing lipid emulsion due to the synergistic effect of the foregoing additives. The drug-containing lipid emulsion is also excellent in storage stability and thus the foregoing lipid emulsion can be applied to drugs such as injections, eye drops, nasal drops, lotions or liniments, inhalants and drugs for oral administration or cosmetics such as humectants.

Stable lipid emulsion

Antibiotics WAP-8294A, A.sub.1, A.sub.2, A.sub.4, AX, AX-8, AX-9 and AX-13 or pharmeceutically acceptable salts thereof produced by a strain belonging to the genus Lysobacter; a method for producing the foregoing antibiotic WAP-8294A comprising the steps of cultivating, in the culture medium, a microorganism belonging to the genus Lysobacter and having an ability of producing the antibiotic WAP-8294A to produce the antibiotic and accumulate it in the culture medium; then recovering the antibiotic; as well as an antibacterial composition comprising the antibiotic or pharmaceutically acceptable salts thereof are herein disclosed. The novel antibiotic WAP-8294A has an excellent therapeutic effect on infectious diseases developed by infection with Gram-positive bacteria, in particular, MRSA and, therefore, the antibiotic is effective for treating diseases including MRSA infectious diseases developed through infection with Gram-positive bacteria as infectious bacteria.

Antibiotic WAP-8294A, method for preparing the same and antibacterial

The tetrazolylphenyl pivalate of the the following general formula or a pharmaceutically acceptable salt thereof: ##STR1## wherein R.sup.1 and R.sup.2 each represents a hydrogen atom, a lower alkyl group or other substituents; an elastase-inhibitory composition, a composition for preventing and treating emphysema and a composition for preventing and treating endotoxin-induced lung disorders each comprising the foregoing tetrazolylphenyl pivalate derivative or a non-toxic or acid-addition salt thereof.

Tetrazolylphenyl pivalate derivatives and medicinal composition

Fluorescent display tube

Cathode ray tube

Growing community of inventors

Tokyo, Japan

Makoto Maeda